论文部分内容阅读
目的研究观察利伐沙班治疗老年恶性肿瘤并发下肢深静脉血栓的疗效。方法选取2013-10-2015-10我院56例老年恶性肿瘤并发下肢深静脉患者,随机分为对照组(低分子肝素组)26例和观察组(利伐沙班组)30例2组。对2组患者的临床疗效及安全性进行评价。结果治疗后,对照组显效13例,有效12例,总有效率为83.33%;观察组显效15例,有效12例,总有效率为90.00%,效果优于对照组,但差异无统计学意义。结论利伐沙班治疗老年恶性肿瘤并发下肢深静脉血栓疗效确切,安全性良好。
Objective To observe the curative effect of rivaroxaban in the treatment of elderly patients with malignant tumor of lower extremity. Methods Totally 56 elderly patients with malignant tumor complicated with deep venous legs in our hospital from 2013-10-2015-10 were randomly divided into control group (low molecular weight heparin group) and observation group (rivaroxaban group). The clinical efficacy and safety of two groups of patients were evaluated. Results After treatment, the control group was significantly improved in 13 cases, effective in 12 cases, the total effective rate was 83.33%; the observation group markedly effective in 15 cases, effective in 12 cases, the total effective rate was 90.00%, the effect is better than the control group, but the difference was not statistically significant . Conclusion Rivaroxaban is effective and safe in the treatment of elderly patients with deep venous thrombosis of lower extremity.